Traditional focus: 1 disease → 1 custom device. BioTrillion’s focus: 1 existing device → multiple diseases.
This software-only approach allows one device (the smartphone) to screen for many conditions, by innovating at the intersection of three key domains:
Smartphones are already in 5 billion hands, yet their cameras remain an untapped opportunity for health monitoring. Manufacturers have invested billions to make these devices ubiquitous and sensor-rich; billions more enhance camera hardware each year. Despite this, the primary application is still photography – we are redefining it for healthcare.
The human face harbours more multimodal health information than any other visible anatomic region. Quantifying these subtle features as digital biomarkers and analysing them combinatorially with our DiseaseSignatures™ engine unlocks:
Our HealthySelfie™ iOS app, powered by BioEngine4D, has been evaluated to quantify ten (10) clinically validated vital signs and digital biomarkers with medical-grade accuracy (~91%) from a 10-second face scan.
For privacy and security, our edge-AI architecture is designed to extract and process all health metrics locally on-device, ensuring images do not leave your smartphone.
Our software-only solution is delivered as a plug-and-play API/SDK that can seamlessly integrate into an enterprise’s existing mobile app on the customer’s smartphone. This allows partners to embed BioTrillion’s analytics into current workflows and data streams with minimal engineering effort.
Traditional clinical trials are often burdened by high costs, logistical hurdles, and protracted timelines, delaying the delivery of life-saving treatments to patients.
The BioEngine4D digital biomarker platform enables remote, precise, and continuous monitoring of medical-grade physiologic endpoints. It minimises subjective assessments, accelerates data capture, and strengthens data integrity — lowering costs and compressing timelines. This shift toward decentralised trials boosts participant compliance and scales efficiently across geographies.
Life insurers face challenges in accurately assessing individual risk, often relying on indirect, generalized, and self-reported data, which can lead to inaccuracies, fraud, and higher costs.
The BioEngine4D software platform offers life insurers a more precise, data-driven approach to risk assessment. By leveraging vital sign data captured through a simple smartphone video, insurers gain direct and objective insights into an individual’s health and longevity risk. This technology not only reduces fraud but also enables more tailored policy offerings, enhancing profitability and consumer adoption.
Health insurers struggle with accurately predicting chronic disease risk, often resulting in increased claims and higher premiums due to inefficient risk stratification.
The BioEngine4D platform empowers health insurers with a more accurate and objective method to assess disease risk. By analyzing vital signs from a quick video, our technology helps insurers identify high-risk individuals early, enabling proactive intervention strategies. This reduces healthcare costs, improves patient outcomes, and ultimately yields a more actuarially sustainable insurance model.
Current telehealth solutions are limited in their ability to provide comprehensive health assessments, as they often lack tools for real-time, remote vital sign monitoring, thereby restricting the quality of care that can be delivered virtually.
Our platform addresses this gap by integrating AI-powered vital sign measurement directly into telehealth services. Our technology transforms any smartphone into a powerful health monitoring tool, enabling healthcare providers to remotely assess multiple vital signs in just seconds. This advancement enriches telehealth consultations with objective health data, enabling platforms to differentiate and empowering clinicians to deliver better-informed care, more billable services, and improved outcomes.
The consumer health industry is increasingly focused on providing tools and services that enable individuals to take control of their health and well-being, yet many existing solutions offer limited insights into chronic disease risks.
We elevate personal health management by enabling multi-disease risk detection through a simple smartphone video. Our technology empowers consumers with actionable health insights, allowing them to track and manage their health more effectively. Whether monitoring the impact of lifestyle changes or detecting early signs of chronic diseases, our solution unlocks the ‘digital doctor’ in everyone’s pocket, enabling improved quality of life and longevity.
Historically, the ability to detect signs of disease required in vivo methods, with invasive procedures into the body.
Today, advancements allow much of this information to be gathered ex vivo, non-invasively, through surface-level contact on the body.
In the future, this evolution will continue to advance, enabling the collection of vital health data telemetrically, away from the body.
This progression—from in vivo (invasive), to ex vivo (invasiveless), to telemetrica (contactless)—reflects the ongoing shift away from physical constraints, exponentially enhancing the convenience and scalability of accessing critical health insights.
Our AI models emulate the centuries-old clinical workflow — observe key biomarkers, analyse them combinatorially, and infer disease risk. DigitalDoctor™ extends that capability to anyone with a smartphone, making objective health monitoring vastly more accessible, frequent, and scalable.
| Domain | Role | Clinical | Digital | Advantage |
|---|---|---|---|---|
| Anatomy | Contains Disease Signs | Blood (Sample) | Face (HealthySelfie) | Convenient; Accessible |
| Sensor | Capture Signs | Lab Sensors | Phone Sensors | Frequent; Instant; Scalable to 5B |
| Processor | Combine Signs + Infer Disease | Human Doctor Brain | DigitalDoctor™ AI | Unlimited Combinatorics; Consistency; Accuracy |
BioEngine4D is a technology platform with the potential to transform health monitoring at digital speed and scale for billions of people, establishing a new paradigm in earlier disease detection and better risk prediction.
We are building a future where virtually anyone, anytime, anywhere has instant and accessible health monitoring abilities — providing better care for your health — with only the device you already hold in your hand.
